… the state-of-the-art of the RSV vaccine research and its implications for clinical practice,
focusing on the characteristics of the vaccines that reached the clinical stage of development. …

… to develop a multiepitope-based subunit vaccine (MEV) using a reverse vaccinology approach
to curb RSV … associated with RSV vaccine development as, they can be used for maternal …

… RSV on human health and how structure-based vaccine design set the stage for numerous
… For several decades, few live attenuated and purified fusion protein or subunit-based vaccine …

… An effective RSV vaccine usually requires both high levels of RSV-neutralizing antibody
and Th1-like cellular immune response (36, 37). To explore the effect of immune routes on …

… Respiratory syncytial virus (RSV)-G glycoprotein subunit vaccine has been studied for its …
Here, we provided a snapshot of protein-subunit-based vaccines and their preclinical and …

… , including protein subunit-based (SUV) and … RSV vaccine also produced in genetically
engineered stable CHO cells by Pfizer, features a bivalent prefusion F formulation targeting RSV …

… According to epidemiological data, there are three target populations that require different
approaches for the RSV vaccine: naive children < 4–6 months, children > 6 months, and >65 …

… , nanoparticle-based, subunit-based, vector-… FI-RSV vaccine has led to prolonged concerns
about vaccine safety. Thus, one challenge in RSV vaccine development is that any vaccine …

… by RSV in this population. However, the development of whole inactivated or subunit-based
vaccines for … elicited by a formalin-inactivated RSV vaccine candidate (FI-RSV). In contrast to …

… In the present study, we provide evidence that single-shot pre-F and N subunit-based
vaccines can protect calves vaccinated in the presence of BRSV-specific MDA. This can be …